Hetero’s COVID-19 ORAL Drug Gets WHO Pre-Qualification . WHO Made a Strong Recommendation For Nirmatrelvir and Ritonavir For Mild And Moderate COIVID19 Patients At Highest Risk of Hospital Admission .